CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Q2 2023 Earnings Call Transcript August 10, 2023
CymaBay Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.21.
Operator: Good day, ladies and gentlemen, and welcome to CymaBay’s Second Quarter 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call for your questions. Please be advised...
